Abstract

As data on the 1997 harvests are being analyzed, agricultural biotechnology-based firms are already moving the next generation of transgenic crops to market. Corn is getting a big push right now. The major ag biotech firms are suing each other (C&EN, Nov. 10, page 6) even as they are expanding their technology and marketing bases. Monsanto, for example, acquired control of Sementes Agroceres, Brazil's leading seed corn company, in late November. And AgrEvo, the Hoechst and Schering joint venture, signed up Garst Seed Co. of Minneapolis to sell corn engineered to be resistant both to insects and AgrEvo's Liberty (glufosinate) herbicide. DowElanco, a subsidiary of Dow Chemical, has joined with Seed Genetics of Indianapolis to market corn hybrids with high oil content. Both DowElanco and AgrEvo anticipate sales beginning in 1998. Already on the market are insect-resistant corn varieties from Monsanto, Novartis, DeKalb Genetics, and Mycogen. Results of Monsanto's first commercial field trials of its ...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.